Skip to content
10-K

Annual Report

Evolutionary Genomics, Inc.

0001553350-23-000160

← back to feed
Filed
Mar 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 1, 2023 6.66M sh
Shares Diluted FY 2022 · Dec 31, 2022 6.46M sh
Shares Diluted FY 2022 · Dec 31, 2021 5.88M sh
Operating Cash Flow FY 2022 · Dec 31, 2022 −$640.95K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$1.58M
Long Term Debt FY 2022 · Dec 31, 2022 $3.74M
Long Term Debt FY 2022 · Dec 31, 2021 $3.74M
Cash And Equivalents FY 2022 · Dec 31, 2022 $577.07K
Cash And Equivalents FY 2022 · Dec 31, 2021 $214.01K
Stockholders Equity FY 2022 · Dec 31, 2022 −$5.59M
Stockholders Equity FY 2022 · Dec 31, 2021 −$4.4M
Stockholders Equity FY 2022 · Dec 31, 2020 −$1.83M
Total Liabilities FY 2022 · Dec 31, 2022 $3.92M
Total Liabilities FY 2022 · Dec 31, 2021 $3.76M
Current Assets FY 2022 · Dec 31, 2022 $698.91K
Current Assets FY 2022 · Dec 31, 2021 $255.8K
Total Assets FY 2022 · Dec 31, 2022 $2.35M
Total Assets FY 2022 · Dec 31, 2021 $2.93M
Eps Diluted FY 2022 · Dec 31, 2022 −$0.35
Eps Diluted FY 2022 · Dec 31, 2021 −$0.52
Eps Basic FY 2022 · Dec 31, 2022 −$0.35
Eps Basic FY 2022 · Dec 31, 2021 −$0.52
Sga Expense FY 2022 · Dec 31, 2022 $1.25M
Sga Expense FY 2022 · Dec 31, 2021 $1.27M
Rd Expense FY 2022 · Dec 31, 2022 $417.45K
Rd Expense FY 2022 · Dec 31, 2021 $1.23M
Net Income FY 2022 · Dec 31, 2022 −$1.93M
Net Income FY 2022 · Dec 31, 2021 −$2.79M
Operating Income FY 2022 · Dec 31, 2022 −$2.01M
Operating Income FY 2022 · Dec 31, 2021 −$2.88M